Class information for:
Level 1: EARLY BACTERICIDAL ACTIVITY//DELAMANID//BEDAQUILINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4611 1683 36.5 67%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
82 26468 TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EARLY BACTERICIDAL ACTIVITY Author keyword 45 94% 1% 16
2 DELAMANID Author keyword 38 93% 1% 14
3 BEDAQUILINE Author keyword 33 83% 1% 19
4 RIFAPENTINE Author keyword 32 65% 2% 31
5 DIARYLQUINOLINE Author keyword 26 100% 1% 11
6 PA 824 Author keyword 25 77% 1% 17
7 INFECT DIS PHARMACOKINET Address 24 57% 2% 28
8 TMC207 Author keyword 22 81% 1% 13
9 R207910 Author keyword 17 100% 0% 8
10 TIBOTEC BVBA Address 15 77% 1% 10

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 EARLY BACTERICIDAL ACTIVITY 45 94% 1% 16 Search EARLY+BACTERICIDAL+ACTIVITY Search EARLY+BACTERICIDAL+ACTIVITY
2 DELAMANID 38 93% 1% 14 Search DELAMANID Search DELAMANID
3 BEDAQUILINE 33 83% 1% 19 Search BEDAQUILINE Search BEDAQUILINE
4 RIFAPENTINE 32 65% 2% 31 Search RIFAPENTINE Search RIFAPENTINE
5 DIARYLQUINOLINE 26 100% 1% 11 Search DIARYLQUINOLINE Search DIARYLQUINOLINE
6 PA 824 25 77% 1% 17 Search PA+824 Search PA+824
7 TMC207 22 81% 1% 13 Search TMC207 Search TMC207
8 R207910 17 100% 0% 8 Search R207910 Search R207910
9 OPC 67683 15 88% 0% 7 Search OPC+67683 Search OPC+67683
10 SQ109 13 67% 1% 12 Search SQ109 Search SQ109

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EARLY BACTERICIDAL ACTIVITY 178 67% 9% 159
2 R207910 115 100% 2% 33
3 DIARYLQUINOLINE TMC207 99 87% 3% 48
4 NITROIMIDAZOPYRAN PA 824 98 84% 3% 53
5 STERILIZING ACTIVITIES 68 84% 2% 37
6 PA 824 67 78% 3% 45
7 PYRAZINAMIDE 56 27% 10% 176
8 MURINE TUBERCULOSIS 49 46% 5% 79
9 ANTITUBERCULOSIS DRUGS 42 29% 7% 121
10 BENZOTHIAZINONES 41 85% 1% 22

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Advances in the development of new tuberculosis drugs and treatment regimens 2013 135 99 59%
The challenge of new drug discovery for tuberculosis 2011 355 60 35%
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects 2014 45 85 48%
Tuberculosis: The drug development pipeline at a glance 2012 65 111 68%
Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls 2014 8 15 87%
Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Tuberculosis 2014 8 23 83%
New drugs for the treatment of tuberculosis: hope and reality 2012 44 88 80%
Profile of delamanid for the treatment of multidrug-resistant tuberculosis 2015 1 18 78%
Tuberculosis drug discovery in the post-post-genomic era 2014 19 60 38%
Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review 2011 28 22 82%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INFECT DIS PHARMACOKINET 24 57% 1.7% 28
2 TIBOTEC BVBA 15 77% 0.6% 10
3 IMED INFECT 12 86% 0.4% 6
4 INFECT DIS EXPT THER EUT 8 100% 0.3% 5
5 TB SECT 6 15% 2.1% 35
6 OFF CRIT PATH PROGRAMS 4 67% 0.2% 4
7 LEAD PROGRAMME TB 4 75% 0.2% 3
8 N AMER PHARMACOKINET 4 56% 0.3% 5
9 UNIT CLIN BIOMED TB 3 43% 0.4% 6
10 TIBOTEC NV 3 100% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000170093 ISONIAZID//ISONICOTINYL HYDRAZONE//ACETYLISONIAZID
2 0.0000168321 MULTIDRUG RESISTANT TUBERCULOSIS//MDR TB//DRUG SUSCEPTIBILITY TESTING
3 0.0000142984 RIFABUTIN//KRM 1648//RIFALAZIL
4 0.0000139217 CAS 58001 44 8//HOSPITAL PATHOGENS//RV3676
5 0.0000129866 ISONIAZID//DRUG REASSESSMENT//DRUG INDUCED HEPATOTOXICITY
6 0.0000121466 CLOFAZIMINE//B669//RIMINOPHENAZINES
7 0.0000100838 DEVR//PE_PGRS//MOL MYCOBACTERIOL UNIT
8 0.0000098787 DIABETE SUCRE//COHORT REPORTS//FIELD HLTH PROGRAMME
9 0.0000097298 CYP ISOZYMES//MOL RECOGNIT TECHNOL DEV IDM//CIENCIAS BASICAS FARMACEUT
10 0.0000096646 AZORELLA COMPACTA//MULINANE//AZORELLA MADREPORICA